Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
Lurasidone HCl is a compound being developed for the treatment of schizophrenia. This
clinical study is designed to test the hypothesis that lurasidone is more efficacious than
placebo. The study will also evaluate the safety and tolerability of lurasidone as compared
to placebo.